Projects per year
Fingerprint
Dive into the research topics where Christine Hafner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Danube-ARC
Valenta, R., Trautinger, F., Errhalt, P., Hafner, C. & Partner, P.
Land NÖ - K3 (Abteilung Wissenschaft und Forschung)
1/08/20 → 31/07/23
Project: Other
-
CSPG4
Hafner, C., Kitzwögerer, M., Breiteneder, H. & Schaider, H.
Gesellschaft für Forschungsförderung NÖ
1/11/16 → 1/11/20
Project: Other
Research output
-
Does pigmentation, hemosiderin and blood effect visible 5-ALA fluorescence in cerebral melanoma metastasis?
Marhold, F., Roetzer-Pejrimovsky, T., Scheichel, F., Mercea, P. A., Mischkulnig, M., Wadiura, L. I., Kiesel, B., Weber, M., Popadic, B., Prihoda, R., Hafner, C. & Widhalm, G., Sep 2022, In: Photodiagnosis and Photodynamic Therapy. 39, p. 102864 102864.Research output: Journal article (peer-reviewed) › Journal article
Open Access1 Citation (Scopus) -
Identification of potentially tolerated fish species by multiplex IgE testing of a multinational fish-allergic patient cohort
Kalic, T., Kuehn, A., Aumayr, M., Bartra, J., Bindslev-Jensen, C., Codreanu-Morel, F., Domínguez, O., Forstenlechner, P., Hemmer, W., Kamath, S. D., Leung, A., Leung, N., Lifanov, Y., Mortz, C. G., Pascal, M., Ristl, R., Sørensen, M., Üzülmez, Ö., Yeghiazaryan, L., Wong, G., & 2 others, Dec 2022, In: Journal of Allergy and Clinical Immunology: In Practice. 10, 12, p. 3284-3292 9 p.Research output: Journal article (peer-reviewed) › Journal article
1 Citation (Scopus) -
Pru du 1, the Bet v 1-homologue from almond, is a major allergen in patients with birch pollen associated almond allergy
Kabasser, S., Crvenjak, N., Schmalz, S., Kalic, T., Hafner, C., Dubiela, P., Kucharczyk, A., Bazan-Socha, S., Lukaszyk, M., Breiteneder, H., Radauer, C. & Bublin, M., Aug 2022, In: Clinical and Translational Allergy. 12, 8, p. e12177 e12177.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Real world outcomes using PD-1 antibodies and BRAF+MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland
Schumann, K., Mauch, C., Klespe, K. C., Loquai, C., Nikfarjam, U., Schlaak, M., Akcetin, L., Kölblinger, P., Hoellwerth, M., Meissner, M., Mengi, G., Braun, A. D., Mengoni, M., Dummer, R., Mangana, J., Sindrilaru, M. A., Radmann, D., Hafner, C., Freund, J., Rappersberger, K., & 48 others, 25 Nov 2022, (E-pub ahead of print) In: Journal of the European Academy of Dermatology and Venereology.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Targeting DNA repair to enhance the efficacy of sorafenib in hepatocellular carcinoma
Samadaei, M., Senfter, D., Madlener, S., Uranowska, K., Hafner, C., Trauner, M., Rohr-Udilova, N. & Pinter, M., Oct 2022, In: Journal of Cellular Biochemistry. 123, 10, p. 1663-1673 11 p.Research output: Journal article (peer-reviewed) › Journal article
Open Access